In this episode, Joe interviews Juan Pablo Cappello: co-founder and former CEO of Nue Life Health, whose assets were subsequently acquired by Beckley Waves. Cappello digs into his recent article which has been making waves across the psychedelic community: “Profit Over Patients? A Critical Look at At-Home Ketamine Therapy.” He created Nue Life with the […]

The post PT496 – Maintenance Doses and Recurring Revenue: The Ethics of At-Home Ketamine Therapy appeared first on Psychedelics Today.

Previous articleFluence’s Elizabeth Nielson on Professional Education for the Psychedelics Field
Next articleThe Psychedelic News Feed: Feb 5, 2024 – Mar 3, 2024